Literature DB >> 9300697

The mouse genes encoding the third pair of beta-type proteasome subunits regulated reciprocally by IFN-gamma: structural comparison, chromosomal localization, and analysis of the promoter.

M Hayashi1, T Ishibashi, K Tanaka, M Kasahara.   

Abstract

Proteasomes are the multisubunit protease involved in the generation of peptides presented by MHC class I molecules. When cells are stimulated with IFN-gamma, two MHC-encoded subunits, low Mr polypeptide 2 (LMP2) and LMP7, are incorporated into the proteasomal complex by displacing the housekeeping subunits, designated Y and X, respectively. Recent evidence indicates that besides the LMP2/Y and LMP7/X subunits, there is another pair of structurally similar beta-type subunits, designated MECL1 and Z, whose expression is regulated reciprocally by IFN-y. In the present study we determined the genomic organizations of the mouse genes, Psmb10 and Psmb7, that encode the MECL1 and Z subunits, respectively. Although the two genes differ > 10-fold in size, they both have eight exons, with the exon-intron boundaries located precisely at the equivalent positions. The organization of the Psmb10 and Psmb7 genes differs from those of the genes encoding the other two pairs of IFN-gamma-regulated subunits. Thus, comparison of the gene structures supports the idea that Psmb10 and Psmb7 arose by duplication from an immediate common ancestor. The promoter region of the Psmb10 gene contains two IFN-stimulated response elements, the functionality of which was confirmed by in vitro mutagenesis. The mouse Psmb10 gene maps to chromosome 8, thus outside the MHC like its human counterpart. Besides the Psmb7 gene previously mapped to chromosome 2, a truncated processed pseudogene, designated Psmb7-ps, was identified and mapped to chromosome X.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300697

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Immunoproteasome deficiency alters retinal proteasome's response to stress.

Authors:  Stacy A Hussong; Rebecca J Kapphahn; Stacia L Phillips; Marcela Maldonado; Deborah A Ferrington
Journal:  J Neurochem       Date:  2010-03-14       Impact factor: 5.372

Review 2.  Immunoproteasomes: structure, function, and antigen presentation.

Authors:  Deborah A Ferrington; Dale S Gregerson
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 3.  Origin and evolution of the specialized forms of proteasomes involved in antigen presentation.

Authors:  Masanori Kasahara; Martin F Flajnik
Journal:  Immunogenetics       Date:  2019-01-24       Impact factor: 2.846

4.  Comparative genomic analysis of the proteasome β5t subunit gene: implications for the origin and evolution of thymoproteasomes.

Authors:  Yoichi Sutoh; Mizuho Kondo; Yuko Ohta; Tatsuya Ota; Utano Tomaru; Martin F Flajnik; Masanori Kasahara
Journal:  Immunogenetics       Date:  2011-07-07       Impact factor: 2.846

5.  Isolation and characterization of lymphocyte-like cells from a lamprey.

Authors:  Werner E Mayer; Tatiana Uinuk-Ool; Herbert Tichy; Lanier A Gartland; Jan Klein; Max D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-18       Impact factor: 11.205

6.  Natural selection during functional divergence to LMP7 and proteasome subunit X (PSMB5) following gene duplication.

Authors:  David H Bos
Journal:  J Mol Evol       Date:  2005-02       Impact factor: 2.395

Review 7.  The Immunoproteasome in oxidative stress, aging, and disease.

Authors:  Helen K Johnston-Carey; Laura C D Pomatto; Kelvin J A Davies
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-04-20       Impact factor: 8.250

Review 8.  Expanding the role of proteasome homeostasis in Parkinson's disease: beyond protein breakdown.

Authors:  Mingxia Bi; Xixun Du; Qian Jiao; Xi Chen; Hong Jiang
Journal:  Cell Death Dis       Date:  2021-02-04       Impact factor: 8.469

9.  9-Gene Signature Correlated With CD8+ T Cell Infiltration Activated by IFN-γ: A Biomarker of Immune Checkpoint Therapy Response in Melanoma.

Authors:  Kexin Yan; Yuxiu Lu; Zhangyong Yan; Yutao Wang
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.